IFNγ released by CD8(+)T cells inhibits the expression of SLC7A11 synergistically, leading to the activation of ferroptosis, thereby enhancing anti-PD-L1 anti-tumor immunotherapy, enhancing lipid oxidation and ferroptosis in tumors, and improving tumor control (110). Here, SLC7A11 is linked to neoplasm.